Clinical Trials Browser

Phase 3 × Serotonin Syndrome × lanreotide × Clear all

NCT00774930 2022-10-14

ELECT

Phase 3 Completed

115 enrolled 17 charts

Carcinoid Tumor, Diarrhea, Flushing, Neuroendocrine Tumors, Serotonin Syndrome

NCT04065165 2020-02-05

TELEFIRST

Phase 3 Withdrawn

Carcinoid Heart Disease, Serotonin Syndrome